An Indian drug firm has promised an Omicron-specific vaccine that it says is “safe, tolerable and immunogenic”. The move comes as the new variant spreads across the country, where millions of people have yet to get their Covid shots.
India reported 317,532 new infections on Thursday, taking the number of cases so far to 38 million, with 487,000 deaths.
